# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...
HC Wainwright & Co. analyst Brandon Folkes assumes Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces...
Maxim Group analyst Michael Okunewitch maintains Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and raises the price targe...